Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
deals
5
×
biotech
boston blog main
boston top stories
life sciences
national blog main
boston
clinical trials
national top stories
san francisco blog main
roche
san francisco top stories
abbvie
alexion pharmaceuticals
allergan
alnylam pharmaceuticals
alzheimer's disease
amgen
azacitidine
beta-thalassemia
biopharmaceutical
boehringer ingelheim
business
cancer
cancer drugs
cobimetinib
crispr
cynthia collins
dacogen
decitabine
dicerna pharamceuticals
dna
editas medicine
epigenetics
epizyme
farydak
fda
flagship pioneering
fulcrum therapeutics
gene editing
What
medicines
5
×
research
5
×
biotech
abbvie
drug
gene
new
abbott
agreement
aims
alliance
announced
approach
backed
based
biopharma
calico
called
cancer
caught
causing
center
companies
company
countries
debuts
despite
developing
dicerna
disease
drugs
editas
editing
employes
epigenetic
epigenetics
exits
experimental
eye
facility
Language
unset
Current search:
medicines
×
research
×
deals
×
@xconomy.com
3 years ago
AbbVie Exits Editas Alliance, Pruning Another Genetic Medicines Pact
@xconomy.com
4 years ago
Revolution Medicines IPO Reels In $238M to Take On RAS in Cancer
@xconomy.com
4 years ago
Roche to Pay Dicerna Pharma $200M to Team Up on Hepatitis B Drug
@xconomy.com
4 years ago
Flagship’s Omega Aims to Take Epigenetic Drugs a Step Further
@venturebeat.com
9 years ago
Google-backed Calico and Abbott Labs spinoff will set up $1.5B research center